174 related articles for article (PubMed ID: 35043958)
1. The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression.
Wahlström G; Heron S; Knuuttila M; Kaikkonen E; Tulonen N; Metsälä O; Löf C; Ettala O; Boström PJ; Taimen P; Poutanen M; Schleutker J
Hum Mol Genet; 2022 Jun; 31(12):2063-2077. PubMed ID: 35043958
[TBL] [Abstract][Full Text] [Related]
2.
Kaikkonen E; Ettala O; Nikulainen I; Taimen P; Lehtinen I; Boström PJ; Kellokumpu-Lehtinen PL; Schleutker J
Anticancer Res; 2019 Oct; 39(10):5353-5359. PubMed ID: 31570429
[TBL] [Abstract][Full Text] [Related]
3. ANO7 is associated with aggressive prostate cancer.
Kaikkonen E; Rantapero T; Zhang Q; Taimen P; Laitinen V; Kallajoki M; Jambulingam D; Ettala O; Knaapila J; Boström PJ; Wahlström G; Sipeky C; Pursiheimo JP; Tammela T; Kellokumpu-Lehtinen PL; ; Fey V; Maehle L; Wiklund F; Wei GH; Schleutker J
Int J Cancer; 2018 Nov; 143(10):2479-2487. PubMed ID: 30157291
[TBL] [Abstract][Full Text] [Related]
4. Transcripts of the Prostate Cancer-Associated Gene
Metsälä O; Wahlström G; Taimen P; Kellokumpu-Lehtinen PL; Schleutker J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674564
[TBL] [Abstract][Full Text] [Related]
5. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
Marx A; Koopmann L; Höflmayer D; Büscheck F; Hube-Magg C; Steurer S; Eichenauer T; Clauditz TS; Wilczak W; Simon R; Sauter G; Izbicki JR; Huland H; Heinzer H; Graefen M; Haese A; Schlomm T; Bernreuther C; Lebok P; Bonk S
Cancer Biol Med; 2021 Feb; 18(1):245-255. PubMed ID: 33628598
[TBL] [Abstract][Full Text] [Related]
6. ANO7 African-ancestral genomic diversity and advanced prostate cancer.
Jiang J; Soh PXY; Mutambirwa SBA; Bornman MSR; Haiman CA; Hayes VM; Jaratlerdsiri W
Prostate Cancer Prostatic Dis; 2023 Sep; ():. PubMed ID: 37749167
[TBL] [Abstract][Full Text] [Related]
7. BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
Morrison A; Chekaluk Y; Bacares R; Ladanyi M; Zhang L
PLoS One; 2015; 10(4):e0119224. PubMed ID: 25830670
[TBL] [Abstract][Full Text] [Related]
8. ANO7: Insights into topology, function, and potential applications as a biomarker and immunotherapy target.
Guo J; Wang D; Dong Y; Gao X; Tong H; Liu W; Zhang L; Sun M
Tissue Cell; 2021 Oct; 72():101546. PubMed ID: 33940566
[TBL] [Abstract][Full Text] [Related]
9. The interactome of the prostate-specific protein Anoctamin 7.
Kaikkonen E; Takala A; Pursiheimo JP; Wahlström G; Schleutker J
Cancer Biomark; 2020; 28(1):91-100. PubMed ID: 32176628
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
11. Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
Phillips JW; Pan Y; Tsai BL; Xie Z; Demirdjian L; Xiao W; Yang HT; Zhang Y; Lin CH; Cheng D; Hu Q; Liu S; Black DL; Witte ON; Xing Y
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5269-5279. PubMed ID: 32086391
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.
Xiao F; Zhang P; Wang Y; Tian Y; James M; Huang CC; Wang L; Wang L
Mol Carcinog; 2020 Jan; 59(1):45-55. PubMed ID: 31659808
[TBL] [Abstract][Full Text] [Related]
13. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
[TBL] [Abstract][Full Text] [Related]
14. SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.
Kawamura N; Nimura K; Saga K; Ishibashi A; Kitamura K; Nagano H; Yoshikawa Y; Ishida K; Nonomura N; Arisawa M; Luo J; Kaneda Y
Cancer Res; 2019 Oct; 79(20):5204-5217. PubMed ID: 31431456
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report.
Agiannitopoulos K; Papadopoulou E; Tsaousis GN; Pepe G; Kampouri S; Kocdor MA; Nasioulas G
BMC Med Genet; 2019 Jul; 20(1):131. PubMed ID: 31349801
[TBL] [Abstract][Full Text] [Related]
16. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data.
Shen S; Park JW; Lu ZX; Lin L; Henry MD; Wu YN; Zhou Q; Xing Y
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5593-601. PubMed ID: 25480548
[TBL] [Abstract][Full Text] [Related]
17. Understanding human DNA variants affecting pre-mRNA splicing in the NGS era.
Dufner-Almeida LG; do Carmo RT; Masotti C; Haddad LA
Adv Genet; 2019; 103():39-90. PubMed ID: 30904096
[TBL] [Abstract][Full Text] [Related]
18. CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice Site.
Yelskaya Z; Bacares R; Salo-Mullen E; Somar J; Lehrich DA; Fasaye GA; Coit DG; Tang LH; Stadler ZK; Zhang L
PLoS One; 2016; 11(11):e0165654. PubMed ID: 27880784
[TBL] [Abstract][Full Text] [Related]
19. Screening of
Montalban G; Bonache S; Moles-Fernández A; Gisbert-Beamud A; Tenés A; Bach V; Carrasco E; López-Fernández A; Stjepanovic N; Balmaña J; Diez O; Gutiérrez-Enríquez S
J Med Genet; 2019 Feb; 56(2):63-74. PubMed ID: 30472649
[TBL] [Abstract][Full Text] [Related]
20. Intron retention: a common splicing event within the human kallikrein gene family.
Michael IP; Kurlender L; Memari N; Yousef GM; Du D; Grass L; Stephan C; Jung K; Diamandis EP
Clin Chem; 2005 Mar; 51(3):506-15. PubMed ID: 15650036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
